Skip to content

SCHEDULE 13G/AAccepted Feb 6, 4:29 PM ET

Neuphoria Therapeutics Inc. SCHEDULE 13G/A

Baselake Partners, LP

Accepted (ET)

4:29 PM

Feb 6, 2026

Filed

Feb 6, 2026

Documents

2

Size

17.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.